Guggenheim Starts Ovid Therapeutics Inc (OVID) at Buy

October 5, 2026 4:07 PM EDT Send to a Friend
Guggenheim analyst Delma Caiati initiates coverage on Ovid Therapeutics Inc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login